CARDAX, INC.
company.status.inactiveCIK 1544238fmd_0BXE749N3TYWAJK95X2243XXDDManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2006 to Mar 31, 2021, 44 periods
| Line item | FY2012 | FY2013 | FY2013 | FY2014 | FY2015 | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenues | 0 | – | – | – | – | 0 | 1 | 2 | 1 | 1 |
| Cost of revenue | – | – | – | – | – | 0 | 0 | 1 | 0 | 0 |
| Gross profit | – | 0 | – | – | – | 0 | 0 | 1 | 0 | 0 |
| Research and development | 1 | – | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling, general and administrative | 1 | – | 3 | 4 | 1 | 1 | 1 | 1 | 1 | 1 |
| Total operating expenses | 2 | – | 4 | 17 | 4 | 2 | 2 | 5 | 4 | 3 |
| Compensation and benefits | – | – | – | – | – | – | 1 | 2 | 2 | 1 |
| Operating income | (3) | – | (4) | (17) | (4) | (2) | (2) | (4) | (4) | (3) |
| Interest expense | 0 | – | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 2 |
| Other non-operating income (expense) | (1) | – | (1) | (0) | 0 | 0 | 0 | (0) | (1) | (2) |
| Income before taxes | (3) | – | (4) | (17) | (4) | (2) | (2) | (4) | (5) | (5) |
| Income tax expense | – | 0 | – | – | – | – | – | – | – | – |
| Net income from continuing operations | (2) | – | (4) | – | – | – | – | – | – | – |
| Net income | (3) | – | (4) | (17) | (4) | (2) | (2) | (4) | (5) | (5) |
| Net income to common shareholders | (3) | – | (4) | (17) | (4) | (2) | (2) | (4) | (5) | (5) |